RH

Reid Huber

Partner @ Third Rock Ventures

Boston, Massachusetts

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Drug Discovery
Clinical Development
Oncology
Hematology
Endocrinology
Cardiovascular Disease
Metabolism
Human Genetics
Autoimmune Diseases
Inflammation
Type 2 Diabetes
Toxicology
Pharmacology
Molecular Biology
Biochemistry
Biomarker Discovery
FDA

Education

Investments

Asher Bio

Series A

Total Funding: $220M

Synnovation Therapeutics

Series A

Total Funding: $100M

Terremoto Biosciences

Series A

Total Funding: $250M

Rapport Therapeutics

Series A

Total Funding: $250M

CARGO Therapeutics

Series A

Total Funding: $200M

Work Experience

ASPEN

2024

  • CEO

    2024

  • Director

    2024

Third Rock Ventures

2018

  • Partner

    2018

Synnovation Therapeutics

2023

  • Director

    2023

Rapport Therapeutics

2022

  • Director

    2022

  • CEO

    2022 - 2023

MOMA Therapeutics

2020

  • Director

    2020

  • CEO

    2020 - 2021

Terremoto Biosciences

2021

  • Director

    2021

Asher Biotherapeutics

2021

  • Director

    2021

insitro

2019

  • Board Observer

    2019

Eastern New Enlgand Board of the American Cancer Society

2020

  • Director

    2020

Partners HealthCare, Innovation Growth Board

2019

  • Director

    2019